Dr. Toru Miyazaki is conducting groundbreaking research on feline chronic kidney disease (CKD) through the development of a potential cure involving the AIM protein. His studies aim to restore kidney function in cats, with clinical trials for the AIM injection drug expected to begin in 2025 and a possible public release by 2027.
